应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ITRM Iterum Therapeutics Plc
未开盘 07-09 16:00:00 EDT
1.06
+0.13
+13.61%
盘后
1.10
+0.04
+3.77%
19:39 EDT
最高
1.07
最低
0.9300
成交量
101.76万
今开
0.9325
昨收
0.9330
日振幅
15.01%
总市值
4,240万
流通市值
4,161万
总股本
4,000万
成交额
101.43万
换手率
2.59%
流通股本
3,925万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Iterum Therapeutics Plc盘中异动 早盘急速下挫5.48%报0.900美元
市场透视 · 05-21
Iterum Therapeutics Plc盘中异动 早盘急速下挫5.48%报0.900美元
Iterum Therapeutics Plc2025财年第一财季实现净利润-4.89百万美元,同比增加31.13%
市场透视 · 05-18
Iterum Therapeutics Plc2025财年第一财季实现净利润-4.89百万美元,同比增加31.13%
Iterum Therapeutics Plc盘中异动 急速上涨6.64%报0.990美元
市场透视 · 05-16
Iterum Therapeutics Plc盘中异动 急速上涨6.64%报0.990美元
Iterum Therapeutics Plc盘中异动 早盘急速拉升5.38%报1.12美元
市场透视 · 04-30
Iterum Therapeutics Plc盘中异动 早盘急速拉升5.38%报1.12美元
Iterum Therapeutics Plc盘中异动 股价大跌18.65%报1.03美元
市场透视 · 04-29
Iterum Therapeutics Plc盘中异动 股价大跌18.65%报1.03美元
Iterum Therapeutics Plc盘中异动 急速拉升6.35%报1.34美元
市场透视 · 04-28
Iterum Therapeutics Plc盘中异动 急速拉升6.35%报1.34美元
Iterum Therapeutics Plc盘中异动 下午盘急速跳水5.00%报1.24美元
市场透视 · 04-25
Iterum Therapeutics Plc盘中异动 下午盘急速跳水5.00%报1.24美元
Iterum Therapeutics Plc盘中异动 大幅下挫5.76%报1.31美元
市场透视 · 04-24
Iterum Therapeutics Plc盘中异动 大幅下挫5.76%报1.31美元
Iterum Therapeutics Plc盘中异动 股价大涨5.83%
市场透视 · 04-22
Iterum Therapeutics Plc盘中异动 股价大涨5.83%
Iterum Therapeutics Plc盘中异动 早盘股价大跌5.56%
市场透视 · 04-21
Iterum Therapeutics Plc盘中异动 早盘股价大跌5.56%
Iterum Therapeutics Plc盘中异动 早盘股价大跌5.36%报1.06美元
市场透视 · 04-16
Iterum Therapeutics Plc盘中异动 早盘股价大跌5.36%报1.06美元
Iterum Therapeutics Plc盘中异动 大幅下挫5.07%报1.31美元
市场透视 · 03-10
Iterum Therapeutics Plc盘中异动 大幅下挫5.07%报1.31美元
Iterum Therapeutics Plc盘中异动 大幅上涨5.26%
市场透视 · 03-04
Iterum Therapeutics Plc盘中异动 大幅上涨5.26%
Iterum Therapeutics Plc盘中异动 大幅下挫5.02%报1.33美元
市场透视 · 03-03
Iterum Therapeutics Plc盘中异动 大幅下挫5.02%报1.33美元
Iterum Therapeutics Plc盘中异动 快速上涨5.32%报1.49美元
市场透视 · 02-13
Iterum Therapeutics Plc盘中异动 快速上涨5.32%报1.49美元
Iterum Therapeutics Plc2024财年实现净利润-24.77百万美元,同比增加35.44%
市场透视 · 02-13
Iterum Therapeutics Plc2024财年实现净利润-24.77百万美元,同比增加35.44%
Iterum Therapeutics Plc盘中异动 早盘急速跳水5.04%
市场透视 · 02-11
Iterum Therapeutics Plc盘中异动 早盘急速跳水5.04%
Iterum Therapeutics Plc盘中异动 大幅下挫6.99%
市场透视 · 02-10
Iterum Therapeutics Plc盘中异动 大幅下挫6.99%
Iterum Therapeutics Plc盘中异动 早盘股价大涨7.38%
市场透视 · 02-07
Iterum Therapeutics Plc盘中异动 早盘股价大涨7.38%
Iterum Therapeutics 2024年第4季度调整后每股亏损$(0.12),优于$(0.21)的预期
财报速递 · 02-07
Iterum Therapeutics 2024年第4季度调整后每股亏损$(0.12),优于$(0.21)的预期
加载更多
公司概况
公司名称:
Iterum Therapeutics Plc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Iterum Therapeutics Plc于2015年6月24日在爱尔兰注册成立.该公司是一家临床阶段的制药公司,致力于开发和商业化苏洛培南,这可能是美国第一个可用的口服培南,也是全球第一个也是唯一一个可用的口服和静脉注射(IV)品牌培南。舒洛培南是一种强效的、静脉递送的硫培南抗生素,对属于被称为革兰氏阴性的生物群的细菌具有活性,会引起尿路和腹腔内感染。
发行价格:
--
{"stockData":{"symbol":"ITRM","market":"US","secType":"STK","nameCN":"Iterum Therapeutics Plc","latestPrice":1.06,"timestamp":1752091200000,"preClose":0.933,"halted":0,"volume":1017572,"hourTrading":{"tag":"盘后","latestPrice":1.1,"preClose":1.06,"latestTime":"19:39 EDT","volume":46841,"amount":50398.33,"timestamp":1752104352030},"delay":0,"floatShares":39254124,"shares":40000000,"eps":-0.928357,"marketStatus":"未开盘","change":0.127,"latestTime":"07-09 16:00:00 EDT","open":0.9325,"high":1.07,"low":0.93,"amount":1014328.3264384799,"amplitude":0.150054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.928357,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752134400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1527220800000,"exchange":"NASDAQ","adjPreClose":0.933,"preHourTrading":{"tag":"盘前","latestPrice":0.934,"preClose":0.933,"latestTime":"09:16 EDT","volume":1608,"amount":1508.6614584,"timestamp":1752066972510},"postHourTrading":{"tag":"盘后","latestPrice":1.1,"preClose":1.06,"latestTime":"19:39 EDT","volume":46841,"amount":50398.33,"timestamp":1752104352030},"volumeRatio":2.190088},"requestUrl":"/m/hq/s/ITRM","defaultTab":"news","newsList":[{"id":"2537939254","title":"Iterum Therapeutics Plc盘中异动 早盘急速下挫5.48%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537939254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537939254?lang=zh_cn&edition=full","pubTime":"2025-05-21 21:59","pubTimestamp":1747835957,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日21时59分,Iterum Therapeutics Plc股票出现异动,股价快速跳水5.48%。截至发稿,该股报0.900美元/股,成交量1.6705万股,换手率0.04%,振幅1.41%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体跌幅为0.60%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521215917a486e6cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521215917a486e6cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","ITRM","LENZ","BK4139"],"gpt_icon":0},{"id":"2536591017","title":"Iterum Therapeutics Plc2025财年第一财季实现净利润-4.89百万美元,同比增加31.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536591017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536591017?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584088,"startTime":"0","endTime":"0","summary":"5月19日,Iterum Therapeutics Plc公布财报,公告显示公司2025财年第一财季净利润为-4.89百万美元,同比增加31.13%;其中营业收入为0.00美元,每股基本收益为-0.14美元。从资产负债表来看,Iterum Therapeutics Plc总负债35.53百万美元,其中短期债务144000.00美元,资产负债比为0.93,流动比率为3.73。机构评级:截至2025年5月19日,当前有2家机构对Iterum Therapeutics Plc目标价做出预测,其中目标均价为7.00美元,其中最低目标价为5.00美元,最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000520a482f13f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000520a482f13f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITRM","LENZ"],"gpt_icon":0},{"id":"2536434384","title":"Iterum Therapeutics Plc盘中异动 急速上涨6.64%报0.990美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536434384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536434384?lang=zh_cn&edition=full","pubTime":"2025-05-17 00:30","pubTimestamp":1747413006,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日00时30分,Iterum Therapeutics Plc股票出现波动,股价大幅拉升6.64%。截至发稿,该股报0.990美元/股,成交量29.7759万股,换手率0.72%,振幅3.97%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.33%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517003006aa2c91a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517003006aa2c91a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ITRM","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2531105574","title":"Iterum Therapeutics Plc盘中异动 早盘急速拉升5.38%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531105574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531105574?lang=zh_cn&edition=full","pubTime":"2025-04-30 22:05","pubTimestamp":1746021921,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日22时05分,Iterum Therapeutics Plc股票出现波动,股价大幅拉升5.38%。截至发稿,该股报1.12美元/股,成交量14.5054万股,换手率0.42%,振幅3.54%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.26%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430220521974ba90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430220521974ba90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","ITRM"],"gpt_icon":0},{"id":"2531621758","title":"Iterum Therapeutics Plc盘中异动 股价大跌18.65%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531621758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531621758?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:31","pubTimestamp":1745933470,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分,Iterum Therapeutics Plc股票出现波动,股价快速跳水18.65%。截至发稿,该股报1.03美元/股,成交量21.6165万股,换手率0.63%,振幅0.79%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体跌幅为1.78%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213110a6cd6943&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213110a6cd6943&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITRM","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2530281738","title":"Iterum Therapeutics Plc盘中异动 急速拉升6.35%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530281738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530281738?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:31","pubTimestamp":1745847068,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时31分,Iterum Therapeutics Plc股票出现波动,股价快速拉升6.35%。截至发稿,该股报1.34美元/股,成交量1.0413万股,换手率0.03%,振幅0.00%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.35%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213108aa2c7cb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213108aa2c7cb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITRM","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2530536161","title":"Iterum Therapeutics Plc盘中异动 下午盘急速跳水5.00%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530536161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530536161?lang=zh_cn&edition=full","pubTime":"2025-04-26 02:45","pubTimestamp":1745606743,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日02时45分,Iterum Therapeutics Plc股票出现波动,股价快速下跌5.00%。截至发稿,该股报1.24美元/股,成交量24.2304万股,换手率0.70%,振幅5.48%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体跌幅为0.16%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504260245449745611a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504260245449745611a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","ITRM"],"gpt_icon":0},{"id":"2529931398","title":"Iterum Therapeutics Plc盘中异动 大幅下挫5.76%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529931398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529931398?lang=zh_cn&edition=full","pubTime":"2025-04-24 21:32","pubTimestamp":1745501520,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日21时32分,Iterum Therapeutics Plc股票出现波动,股价快速下挫5.76%。截至发稿,该股报1.31美元/股,成交量2.8714万股,换手率0.08%,振幅2.16%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.31%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504242132009743a768&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504242132009743a768&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ITRM","LENZ","BK4007"],"gpt_icon":0},{"id":"2529534419","title":"Iterum Therapeutics Plc盘中异动 股价大涨5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529534419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529534419?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:40","pubTimestamp":1745340049,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时40分,Iterum Therapeutics Plc股票出现异动,股价大幅上涨5.83%。截至发稿,该股报1.09美元/股,成交量17.774万股,换手率0.51%,振幅4.85%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为1.97%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230040499740e737&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230040499740e737&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","ITRM","LENZ"],"gpt_icon":0},{"id":"2529388633","title":"Iterum Therapeutics Plc盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529388633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529388633?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:22","pubTimestamp":1745245359,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时22分,Iterum Therapeutics Plc股票出现波动,股价急速跳水5.56%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.02%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222239a4612bb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222239a4612bb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ITRM","BK4139","BK4007"],"gpt_icon":0},{"id":"2527242283","title":"Iterum Therapeutics Plc盘中异动 早盘股价大跌5.36%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527242283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527242283?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:07","pubTimestamp":1744812477,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时07分,Iterum Therapeutics Plc股票出现波动,股价大幅下跌5.36%。截至发稿,该股报1.06美元/股,成交量5.706万股,换手率0.17%,振幅4.91%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体跌幅为1.39%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220757a45b35d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220757a45b35d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ITRM"],"gpt_icon":0},{"id":"2518275892","title":"Iterum Therapeutics Plc盘中异动 大幅下挫5.07%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275892?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:41","pubTimestamp":1741617691,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时41分,Iterum Therapeutics Plc股票出现异动,股价大幅下跌5.07%。截至发稿,该股报1.31美元/股,成交量10.2168万股,换手率0.30%,振幅3.62%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.08%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310224131a26a3fa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310224131a26a3fa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ITRM","LENZ","BK4139"],"gpt_icon":0},{"id":"2517063985","title":"Iterum Therapeutics Plc盘中异动 大幅上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517063985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517063985?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:27","pubTimestamp":1741120037,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时27分,Iterum Therapeutics Plc股票出现异动,股价急速上涨5.26%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.21%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042717989bfd9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042717989bfd9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITRM","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2516652370","title":"Iterum Therapeutics Plc盘中异动 大幅下挫5.02%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652370?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:38","pubTimestamp":1741027105,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时38分,Iterum Therapeutics Plc股票出现波动,股价快速跳水5.02%。截至发稿,该股报1.33美元/股,成交量17.7237万股,换手率0.51%,振幅9.81%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.57%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC是一家制药公司,致力于最大限度地发挥Orlynvah的商业潜力,Orlynvah是一种口服品牌青霉烯,可在美国使用,可能是全球第一个也是唯一一个口服和静脉注射品牌青霉烯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040238259637e4da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040238259637e4da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ITRM","LENZ","BK4139"],"gpt_icon":0},{"id":"2511573781","title":"Iterum Therapeutics Plc盘中异动 快速上涨5.32%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511573781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511573781?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:54","pubTimestamp":1739469255,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日01时54分,Iterum Therapeutics Plc股票出现波动,股价大幅拉升5.32%。截至发稿,该股报1.49美元/股,成交量22.1056万股,换手率0.64%,振幅8.51%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.99%。其相关个股中,Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大,Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm Plc较为活跃,换手率分别为3011.49%、1443.98%、1210.44%,振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ,振幅分别为733.31%、95.15%、92.30%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214015416abcdda39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214015416abcdda39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ITRM","LENZ","BK4007"],"gpt_icon":0},{"id":"2511522893","title":"Iterum Therapeutics Plc2024财年实现净利润-24.77百万美元,同比增加35.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511522893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511522893?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:00","pubTimestamp":1739462438,"startTime":"0","endTime":"0","summary":"2月14日,Iterum Therapeutics Plc公布财报,公告显示公司2024财年净利润为-24.77百万美元,同比增加35.44%;其中营业收入为0.00美元,每股基本收益为-1.26美元。从资产负债表来看,Iterum Therapeutics Plc总负债48.68百万美元,其中短期债务14.53百万美元,资产负债比为0.92,流动比率为1.41。机构评级:截至2025年2月14日,当前有1家机构对Iterum Therapeutics Plc目标价做出预测,其中目标均价为10.00美元,其中最低目标价为10.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214000051abcdc3e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214000051abcdc3e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITRM","LENZ"],"gpt_icon":0},{"id":"2510336882","title":"Iterum Therapeutics Plc盘中异动 早盘急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510336882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510336882?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:42","pubTimestamp":1739288540,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时42分,Iterum Therapeutics Plc股票出现波动,股价急速下挫5.04%。截至发稿,该股报1.32美元/股,成交量14.3285万股,换手率0.41%,振幅4.94%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体跌幅为1.82%。其相关个股中,Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2710.60%、1083.86%、374.84%,振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.,振幅分别为58.60%、57.43%、37.99%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112342209881ca4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112342209881ca4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ITRM","BK4139"],"gpt_icon":0},{"id":"2510782863","title":"Iterum Therapeutics Plc盘中异动 大幅下挫6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510782863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510782863?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197904,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分,Iterum Therapeutics Plc股票出现异动,股价急速下挫6.99%。截至发稿,该股报1.33美元/股,成交量15.9955万股,换手率0.46%,振幅1.40%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.38%。其相关个股中,Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃,换手率分别为1459.08%、835.01%、550.39%,振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm Plc、Kazia Therapeutics Limited,振幅分别为6.44%、5.96%、4.90%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223144abc9a4f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223144abc9a4f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ITRM","BK4007"],"gpt_icon":0},{"id":"2509744449","title":"Iterum Therapeutics Plc盘中异动 早盘股价大涨7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509744449?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:31","pubTimestamp":1738938675,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时31分,Iterum Therapeutics Plc股票出现波动,股价大幅拉升7.38%。Iterum Therapeutics Plc股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028 Cl A、Tonix Pharmaceuticals Holding Corp.涨幅较大,Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃,换手率分别为963.29%、37.46%、32.79%,振幅较大的相关个股有Passage Bio, Inc.、Maze Therapeutics, Inc.、Iterum Therapeutics Plc,振幅分别为6.39%、6.23%、6.04%。Iterum Therapeutics Plc公司简介:Iterum Therapeutics PLC 是一家临床阶段的制药公司。其苏洛培南项目有潜力解决抗生素耐药性问题和现有药物的毒性限制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223115a23d22f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223115a23d22f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","ITRM"],"gpt_icon":0},{"id":"1135564552","title":"Iterum Therapeutics 2024年第4季度调整后每股亏损$(0.12),优于$(0.21)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1135564552","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135564552?lang=zh_cn&edition=full","pubTime":"2025-02-07 20:08","pubTimestamp":1738930102,"startTime":"0","endTime":"0","summary":"Iterum Therapeutics报告季度每股亏损$,比分析师一致预期的$高出42.86%。相比去年同期$的每股亏损,这一数字增长了85.19%。以上内容来自Benzinga Earnings专栏,原文如下:Iterum $Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 42.86 percent. This is a 85.19 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITRM","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iterumtx.com","stockEarnings":[{"period":"1week","weight":0.095},{"period":"1month","weight":0.0392},{"period":"3month","weight":-0.0364},{"period":"6month","weight":-0.3576},{"period":"1year","weight":-0.2148},{"period":"ytd","weight":-0.4011}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Iterum Therapeutics Plc于2015年6月24日在爱尔兰注册成立.该公司是一家临床阶段的制药公司,致力于开发和商业化苏洛培南,这可能是美国第一个可用的口服培南,也是全球第一个也是唯一一个可用的口服和静脉注射(IV)品牌培南。舒洛培南是一种强效的、静脉递送的硫培南抗生素,对属于被称为革兰氏阴性的生物群的细菌具有活性,会引起尿路和腹腔内感染。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.054522},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.031015},{"month":3,"riseRate":0.428571,"avgChangeRate":0.03951},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.003506},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.011866},{"month":6,"riseRate":0.25,"avgChangeRate":-0.066662},{"month":7,"riseRate":0.375,"avgChangeRate":-0.095953},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.104988},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.113033},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.165968},{"month":11,"riseRate":0.571429,"avgChangeRate":0.369843},{"month":12,"riseRate":0.428571,"avgChangeRate":0.057458}],"exchange":"NASDAQ","name":"Iterum Therapeutics Plc","nameEN":"Iterum Therapeutics Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Iterum Therapeutics Plc(ITRM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Iterum Therapeutics Plc(ITRM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Iterum Therapeutics Plc,ITRM,Iterum Therapeutics Plc股票,Iterum Therapeutics Plc股票老虎,Iterum Therapeutics Plc股票老虎国际,Iterum Therapeutics Plc行情,Iterum Therapeutics Plc股票行情,Iterum Therapeutics Plc股价,Iterum Therapeutics Plc股市,Iterum Therapeutics Plc股票价格,Iterum Therapeutics Plc股票交易,Iterum Therapeutics Plc股票购买,Iterum Therapeutics Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Iterum Therapeutics Plc(ITRM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Iterum Therapeutics Plc(ITRM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}